Mereo BioPharma Group plc - MREO
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | — | A | A | 66,000.0 | 0.0 | 0.0 | 66,000.0 | View | |
| Feb 27, 2026 | — | A | A | 66,000.0 | 0.0 | 0.0 | 66,000.0 | View | |
| Feb 27, 2026 | — | A | A | 117,533.0 | — | — | 117,533.0 | View | |
| Feb 27, 2026 | — | A | A | 66,000.0 | 0.0 | 0.0 | 66,000.0 | View | |
| Feb 27, 2026 | — | A | A | 96,163.0 | — | — | 96,163.0 | View | |
| Feb 27, 2026 | — | A | A | 66,000.0 | 0.0 | 0.0 | 66,000.0 | View | |
| Feb 27, 2026 | — | A | A | 96,163.0 | — | — | 96,163.0 | View | |
| Feb 27, 2026 | — | A | A | 66,000.0 | 0.0 | 0.0 | 66,000.0 | View | |
| Feb 27, 2026 | — | A | A | 133,560.0 | — | — | 133,560.0 | View | |
| Feb 27, 2026 | — | A | A | 66,000.0 | 0.0 | 0.0 | 66,000.0 | View | |
| Feb 27, 2026 | — | A | A | 106,848.0 | — | — | 106,848.0 | View | |
| Feb 27, 2026 | — | A | A | 66,000.0 | 0.0 | 0.0 | 66,000.0 | View | |
| Feb 27, 2026 | — | A | A | 106,848.0 | — | — | 106,848.0 | View | |
| Feb 27, 2026 | — | A | A | 66,000.0 | 0.0 | 0.0 | 66,000.0 | View | |
| Feb 02, 2026 | Chief Financial Officer | A | A | 280,000.0 | 0.0 | 0.0 | 280,000.0 | View | |
| Feb 02, 2026 | Chief Financial Officer | A | A | 105,250.0 | 0.0 | 0.0 | 105,250.0 | View | |
| Feb 02, 2026 | Chief Financial Officer | A | A | 315,750.0 | 0.0 | 0.0 | 315,750.0 | View | |
| Feb 02, 2026 | General Counsel | A | A | 295,000.0 | 0.0 | 0.0 | 295,000.0 | View | |
| Feb 02, 2026 | General Counsel | A | A | 105,250.0 | 0.0 | 0.0 | 105,250.0 | View | |
| Feb 02, 2026 | General Counsel | A | A | 315,750.0 | 0.0 | 0.0 | 315,750.0 | View | |
| Feb 02, 2026 | See Remarks | A | A | 195,000.0 | 0.0 | 0.0 | 195,000.0 | View | |
| Feb 02, 2026 | See Remarks | A | A | 61,250.0 | 0.0 | 0.0 | 61,250.0 | View | |
| Feb 02, 2026 | See Remarks | A | A | 183,750.0 | 0.0 | 0.0 | 183,750.0 | View | |
| Feb 02, 2026 | Chief Scientific Officer | A | A | 145,000.0 | 0.0 | 0.0 | 145,000.0 | View | |
| Feb 02, 2026 | Chief Scientific Officer | A | A | 46,637.0 | 0.0 | 0.0 | 46,637.0 | View | |
| Feb 02, 2026 | Chief Scientific Officer | A | A | 139,913.0 | 0.0 | 0.0 | 139,913.0 | View | |
| Feb 02, 2026 | Chief Executive Officer | A | A | 480,000.0 | 0.0 | 0.0 | 480,000.0 | View | |
| Feb 02, 2026 | Chief Executive Officer | A | A | 345,000.0 | 0.0 | 0.0 | 345,000.0 | View | |
| Feb 02, 2026 | Chief Executive Officer | A | A | 1,035,000.0 | 0.0 | 0.0 | 1,035,000.0 | View |